DOES hemopressin bind metal ions in vivo?

Area of Science:

• Biochemistry
• Neuroendocrinology
• Coordination Chemistry

Background:

• Hemopressin is a neuropeptide derived from hemoglobin with known pharmacological effects.
• Hemopressin and its derivatives (Pepcans) possess metal-binding properties due to specific amino acid residues.
• The biological relevance of metal ion interactions with hemopressin remains largely unexplored.

Purpose of the Study:

• To investigate the complex-formation equilibria of human hemopressin and its analogues with Cu(II) and Ni(II) ions.
• To elucidate the coordination sites and behavior of hemopressin and related peptides in metal ion complexation.
• To understand how structural variations in hemopressin derivatives affect their metal-binding properties.

Main Methods:

• Synthesis and characterization of hemopressin and three analogues.
• Potentiometric and spectroscopic studies to determine complex formation constants.
• Analysis of protonation and complexation behavior with Cu(II) and Ni(II) ions.

Main Results:

• The amino terminus is the primary coordination site for Cu(II) and Ni(II) in hemopressin, unless protected.
• The C-terminal histidine residue acts as an anchoring site, forming macrochelate complexes at acidic pH.
• N-terminal extensions in Pepcans significantly alter protonation and metal-binding characteristics, influenced by ligand charge and coordination environment.

Conclusions:

• Hemopressin and its derivatives exhibit distinct metal-binding behaviors governed by their N-terminus and histidine residue.
• Structural modifications, such as N-terminal extensions, lead to predictable changes in metal coordination.
• This study provides foundational insights into the metal-binding properties of hemopressin peptides, potentially informing their in vivo mechanisms of action.